Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents
- PMID: 19340573
- DOI: 10.1007/s11055-009-9146-2
Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents
Abstract
The efficacy of piracetam in treating the sequelae of moderate and severe closed craniocerebral trauma (CCT) in adolescents was evaluated in studies of 42 patients aged 12-18 years who had suffered CCT 1.5-5 years prior to the study. Adolescents of the experimental group (20 individuals) received piracetam (Nootropil) at doses of 40-50 mg/kg (daily daily 1600-2400 mg) for one month; patients of group 2 (22 individuals) served as controls. Piracetam was found to have positive therapeutic effects on impairments to higher mental (memory, attention, executive) and motor (coordination) functions and on measures of the speeds of cognitive and motor operations.
Similar articles
-
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.Drugs. 2010 Feb 12;70(3):287-312. doi: 10.2165/11319230-000000000-00000. Drugs. 2010. PMID: 20166767 Review.
-
[The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(3):43-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PMID: 18427539 Russian.
-
[A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(3):33-42. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PMID: 18697252 Russian. No abstract available.
-
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.Neurosci Behav Physiol. 2009 Mar;39(3):311-21. doi: 10.1007/s11055-009-9128-4. Neurosci Behav Physiol. 2009. PMID: 19234797 No abstract available.
-
Piracetam--an old drug with novel properties?Acta Pol Pharm. 2005 Sep-Oct;62(5):405-9. Acta Pol Pharm. 2005. PMID: 16459490 Review.
Cited by
-
Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?PM R. 2014 Sep;6(9):814-24. doi: 10.1016/j.pmrj.2014.04.004. Epub 2014 Apr 19. PM R. 2014. PMID: 24755513 Free PMC article.
-
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.Drugs. 2010 Feb 12;70(3):287-312. doi: 10.2165/11319230-000000000-00000. Drugs. 2010. PMID: 20166767 Review.
-
Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.Acta Neurochir (Wien). 2023 Aug;165(8):2201-2210. doi: 10.1007/s00701-023-05674-8. Epub 2023 Jun 29. Acta Neurochir (Wien). 2023. PMID: 37380907
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources